Of the 297 (48.7%) with diabetes, 11 (3.7%) had type 1 diabetes mellitus, 268 (90.2%) had T2DM (122 (45.5%) insulin-treated), 12 (4.0%) had new-onset diabetes after transplant (NODAT), and 6 (2.0%) were classified as other. This evidence concerns the gene INS and diabetes mellitus.